1,018
Views
1
CrossRef citations to date
0
Altmetric
Articles

Prevalence of Trachoma and Access to Water and Sanitation in Benue State, Nigeria: Results of 23 Population-Based Prevalence Surveys

, , , , , , , , , , , , , , & show all
Pages 79-85 | Received 13 Jan 2018, Accepted 13 Apr 2018, Published online: 31 Dec 2018

ABSTRACT

Purpose: We sought to determine the prevalence of trachoma in each local government area (LGA) of Benue State, Nigeria.

Methods: Two-stage cluster sampling was used to conduct a series of 23 population-based prevalence surveys. LGAs were the evaluation units surveyed. In each LGA, 25 households were selected in each of 25 clusters, and individuals aged 1 year and above resident in those households were invited to be examined for trachoma. Data on access to water and sanitation were also collected at household level.

Results: A total of 91,888 people were examined from among 93,636 registered residents across the 23 LGAs. The LGA-level prevalence of trachomatous inflammation—follicular (TF) in 1–9 year olds ranged from 0.3% to 5.3%. Two LGAs had TF prevalences of 5.0–9.9%. The LGA-level prevalence of trichiasis in ≥15-year-olds ranged from 0.0% to 0.35%. Access to improved drinking water sources ranged from 0% in Gwer West to 99% in Tarka, while access to improved sanitation ranged from 1% in Gwer West to 92% in Oturkpo.

Conclusion: There is a need for public health-level interventions against trachoma in three LGAs of Benue State.

Introduction

Trachoma is the world’s most common infectious cause of blindness.Citation1 The disease is caused by repeated boutsCitation2 of infection with the obligate intracellular bacterium Chlamydia trachomatis, which passes from person to person through contaminated hands, through clothes and bedding, and via the eye-seeking fly, Musca sorbens.Citation3 Trachoma disappeared from most developed countries decades ago, but it continues to be a public health problem in much of Africa,Citation4,Citation5 including Nigeria.Citation6

In 1996, the World Health Organization (WHO) established the WHO Alliance for the Global Elimination of Trachoma by 2020 (GET2020).Citation7 The comprehensive strategy to achieve elimination goes by the acronym “SAFE,” which represents surgery, antibiotics, facial cleanliness, and environmental improvement.Citation8 The need for SAFE strategy implementation is determined on the basis of prevalence estimates of trichiasis in ≥15-year-olds and trachomatous inflammation—follicular (TF) in 1-9-year-olds.Citation9 WHO recommends use of the SAFE strategy until elimination threshold prevalences (trichiasis <0.2% in ≥15-year-olds and TF <5% in 1-9-year-olds) are reached in each formerly endemic district.Citation9,Citation10

From 2012 to 2016, members of the WHO Alliance for GET2020 made considerable progress in baseline mapping of suspected trachoma-endemic districts worldwide within the Global Trachoma Mapping Project (GTMP).Citation11 Its goal was to provide a complete picture of the global burden of trachoma, enabling all stakeholders to see where work was needed to achieve elimination as a public health problem.Citation12 Though many other states of Nigeria had previously been mapped for trachoma,Citation13Citation25 no population-based surveys had been undertaken in Benue State, despite the fact that SAFE interventions had been required in neighbouring Nasarawa State, including in a number of bordering local government areas (LGAs).Citation13

The work described here was therefore conducted to (a) determine the LGA-level prevalence of TF and trichiasis in Benue, (b) determine LGA-level prevalence of access to improved water and sanitation, and (c) estimate the likely number of doses of antibiotics and the number of people to be managed for trichiasis that will be needed in Benue State in order to meet the targets of GET2020.

Methods

Study design and setting

Surveys were undertaken between April and September 2014, following standard GTMP procedures, as described previously.Citation26 Benue State, located in the north–central zone of Nigeria, has an ethnically diverse population, which was estimated to total 4.3 million people at the last (2006) census.Citation27 Benue contains 23 LGAs within a land area of 34,059 km.Citation2

Field team preparation

Teams were trained using version 2 of the GTMP training system.Citation28 To be certified to participate in the surveys, graders were required to pass a 50-subject inter-grader agreement test in the field, with the assessments of a GTMP-certified grader trainer used as the reference. Data recorders were also required to pass a test before deployment.Citation26

Sampling and field procedures

LGAs were the units of evaluation. Two-stage cluster sampling was undertaken. We used villages as first-stage clusters, choosing 25 of them from each of the 23 LGAs, with probability of selection proportional to village size.Citation9 From each village, 25 households were selected using the random walk technique, though we are aware of its limitations, detailed elsewhere.Citation18,Citation29Citation31 With a resident’s help, the centre of the village was located and from that starting position a direction for household sampling was selected by spinning a pen and letting it fall to the ground. All residents aged ≥1 year living in the 25 households found on the heading indicated by the pen’s tip were invited to participate. This sampling strategy was designed to promote recruitment of a sample of at least 1019 children aged 1–9 years, as outlined previously.Citation26

At each household, we collected GPS data on household location, the type of and distance to sources of drinking and washing water in the dry season, the setting (e.g., type of shared or private latrine, outside near the home, in the bush or field) in which household adults usually defecated, the presence or absence of a handwashing facility within 15 m of the latrine (if a latrine was used), and the presence or absence of water and soap at the handwashing facility (if a handwashing facility was present). This information was obtained through questions asked of a household key informant and by direct inspection.Citation28 Questions conformed closely to those used up to the year 2015 by the WHO/UNICEF Joint Monitoring Programme for Water Supply and Sanitation.Citation32,Citation33 From each participant, we collected data on age, gender, and presence or absence of trichiasis, TF, and trachomatous inflammation—intense (TI).Citation34

Operational definitions

Graders adhered to the definitions of signs in the WHO simplified trachoma grading system.Citation34 An “improved” water source was defined as one that, by nature of its construction, adequately protects the water from outside contamination, in particular from faecal matter. An improved sanitation facility was defined as one that hygienically separates human excreta from human contact.Citation32

Data management

Data were cleaned by an independent data manager (RW), approved by the health ministry, then analysed; outputs were again approved by health ministry.Citation26 Cluster-level proportions of children with TF were adjusted for age in 1-year bands, and proportions of adults with trichiasis were adjusted for gender and age in 5-year bands; local 2006 census dataCitation27 were used for this adjustment process. LGA-level prevalences were calculated as the means of adjusted cluster-level proportions. Confidence intervals (CIs) were determined by bootstrapping: sets of 25 adjusted cluster-level proportions were selected, with replacement, over 10,000 replications, then the 2.5th and 97.5th percentiles of the ordered means of those sets formed the lower and upper bounds of the CI.

Ethical considerations

Surveys were approved by the Ethics Committee of the London School of Hygiene & Tropical Medicine (6319) and the National Health Research Ethics Committee of Nigeria (NHREC/01/01/2007). The Benue State Ministry of Health gave permission for work to proceed and oversaw its implementation. Informed verbal consent was obtained from each participant or their parent or guardian. We adhered to the principles of the Declaration of Helsinki.Citation35 All data were collected into the Open Data Kit Android smartphone application, LINKS-GTMP, encrypted during transport, and stored in a password-protected database in the cloud to ensure confidentiality, fidelity, and accessibility.Citation26,Citation36 Subjects with active trachoma were given antibioticsCitation37; those who needed trichiasis surgeryCitation38 were referred to the nearest provider.

Results

A total of 93,636 participants were enumerated across the 23 LGAs; 91,888 (98%) consented to participate and were examined, 602 refused participation, and 1146 were absent. The age of participants ranged from 1 year to 100 years (mean 18.3 years).

Prevalence of trachoma

Some 43,640 1-9-year-olds were examined. The LGA-level prevalence of TF among 1-9-year-olds ranged from 0.3% to 5.3% (). Two LGAs had TF prevalences of 5.0–9.9% among 1-9-year-olds. The remaining LGAs had TF prevalences of <5% ().

Table 1. Local Government Area-level prevalence of trichiasis in ≥15-year-olds and prevalence of trachomatous inflammation—follicular (TF) in 1-9-year-olds, Global Trachoma Mapping Project, Benue State, Nigeria, April–September 2014.

A total of 36,802 persons aged ≥15 years were examined. There were 42 adults with trichiasis, giving an overall (unadjusted) prevalence of trichiasis of 0.11% in examined ≥15-year-olds. The LGA-level trichiasis prevalence ranged between 0% (15 LGAs) and 0.35% (95%CI 0.12–0.50) in Okpokwu (). Twenty-one (91% of) LGAs had trichiasis prevalence estimates of <0.2% in adults. In the two LGAs with prevalence estimates of ≥0.2%, the estimated number of individuals needed to be managed to reduce the prevalence to less than the elimination threshold, ignoring incident disease and mortality in those with trichiasis, is 869.

Access to water and sanitation

More than half of all participants (57%) lived in households without a latrine facility, in which adult residents defecated either in the bush or in the open near the household. At LGA level, the proportion of households with access to improved sanitation ranged from 1% in Gwer West to 92% in Oturkpo. In only two of 23 LGAs did ≥80% of households have access to improved sanitation facilities, while only one (Tarka) of 23 LGAs had ≥80% of households with access to an improved water source ().

Table 2. Household-level access to improved water and sanitation facilities by Local Government Area, Global Trachoma Mapping Project, Benue State, Nigeria, April–September 2014.

Discussion

Trachoma remains endemic in many parts of Nigeria. Many LGAs in states other than Benue need to implement the “SAFE” strategy to eliminate the condition as a public health problem. We have surveyed each of Benue State’s 23 LGAs, and found prevalence estimates of TF and trichiasis that are very modest in comparison to more northern states of Nigeria,Citation13,Citation14,Citation17,Citation22Citation25,Citation39,Citation40 or other settings in sub-Saharan Africa.Citation41Citation45 Only two LGAs (Gwer East and Okpokwu) require public health-level implementation of the S component of the SAFE strategy. Only two LGAs (Gwer East and Ukum) had TF prevalences suggesting a need for the A, F, and E components of SAFE. Both of the latter LGAs had TF prevalence estimates just above the 5% elimination threshold, with 95%CI lower bounds from 3.0% to 4.0%, and it is eminently possible that these estimates are simply statistical outliers, rather than representations of ongoing C. trachomatis transmission that should trigger public health concern. However, hard thresholds for elimination must be (and have been) defined, and implementation of interventions for neglected tropical disease elimination is justifiable in such cases on the basis of apparent very low risk, high community acceptability, and a range of benefits to communities beyond simply bringing about the end of the diseases in question.Citation46Citation52

Trachoma prevalence was low in Benue State despite inadequate access to water and sanitation (). Though recent workCitation53,Citation54 has begun to explore levels of community WASH coverage that might associate with lower risk of active trachoma, it does not necessarily follow that particular coverage levels are necessary or sufficient for active trachoma to be eliminated. Regardless, water and sanitation are human rights, and extension of these services to all residents of Benue should be vigorously pursued.

Our surveys had some limitations, including the relatively low numbers of adults examined in several LGAs (771 in Tarka, 997 in Guma; in both of these LGAs no examined adults had trichiasis) and the lack of data on the presence or absence of trachomatous conjunctival scar in eyes diagnosed as having trichiasis. However, the very low prevalences of trichiasis observed almost uniformly across the state would support an assertion that trachoma is close to being eliminated in this setting.

Implementation of community-based trichiasis surgery in the two LGAs observed to have above-elimination-threshold prevalences will help to both maximize the chance that impact surveys will return prevalence estimates below the threshold, and prepare the health system for routine delivery of such services, as and when needed, in the post-validation phase. Human resources, training, equipment, consumables, and funding for trichiasis case finding will be required. Although we estimated the number of cases of trichiasis that would need to be appropriately managed in order to achieve sub-threshold trichiasis prevalences (), we caution that such calculations ignore incident cases and are therefore only valid if interventions are conducted immediately after the prevalence survey underlying the calculations.

Trachoma is a public health problem in some LGAs of Benue State, and relevant stakeholders are urged to support the Ministry of Health to tackle the problem in order to achieve trachoma’s elimination as a public health problem.

Declaration of interest

None of the authors have any proprietary or conflict of interest with this submission. The authors alone are responsible for the writing and content of this article.

Additional information

Funding

This study was principally funded by the GTMP grant from the United Kingdom’s Department for International Development (DFID; ARIES: 203145) to Sightsavers, which led a consortium of non-governmental organizations and academic institutions to support health ministries to complete baseline trachoma mapping worldwide. The GTMP was also funded by the United States Agency for International Development (USAID), through the ENVISION project implemented by RTI International under cooperative agreement number AID-OAA-A-11-00048, and the END in Asia project implemented by FHI360 under cooperative agreement number OAA-A-10-00051. A committee established in March 2012 to examine issues surrounding completion of global trachoma mapping was initially funded by a grant from Pfizer to the International Trachoma Initiative. AWS was a Wellcome Trust Intermediate Clinical Fellow (098521) at the London School of Hygiene & Tropical Medicine and is now, like SB, a staff member of WHO. The authors alone are responsible for the views expressed in this article and they do not necessarily represent the views, decisions, or policies of the institutions with which they are affiliated. None of the funders had any role in project design, in project implementation or analysis or interpretation of data, in the decisions on where, how, or when to publish in the peer-reviewed press, or in the preparation of the manuscript.

References

  • Bourne RR, Stevens GA, White RA, et al. Causes of vision loss worldwide, 1990-2010: a systematic analysis. Lancet Global Health. 2013;1(6):e339–49. doi:10.1016/S2214-109X(13)70113-X.
  • Gambhir M, Basanez MG, Burton MJ, et al. The development of an age-structured model for trachoma transmission dynamics, pathogenesis and control. PLoS Negl Trop Dis. 2009;3(6):e462. doi:10.1371/journal.pntd.0000462.
  • Emerson PM Ecology and control of the trachoma vector Musca sorbens [available at http://etheses.dur.ac.uk/3995/; downloaded 13 July 2012 [Doctor of Philosophy thesis]. Durham: University of Durham; 2001.
  • Smith JL, Flueckiger RM, Hooper PJ, et al. The geographical distribution and burden of trachoma in Africa. PLoS Negl Trop Dis. 2013;7(8):e2359. doi:10.1371/journal.pntd.0002359.
  • World Health Organization. WHO Alliance for the Global Elimination of Trachoma by 2020: progress report on elimination of trachoma, 2014-2016. Wkly Epidemiol Rec. 2017;92(26):359–368.
  • Smith JL, Sivasubramaniam S, Rabiu MM, Kyari F, Solomon AW, Gilbert C. Multilevel analysis of trachomatous trichiasis and corneal opacity in Nigeria: the role of environmental and climatic risk factors on the distribution of disease. PLoS Negl Trop Dis. 2015;9(7):e0003826. doi:10.1371/journal.pntd.0003826.
  • World Health Organization. Planning for the Global Elimination of Trachoma (GET): Report of a WHO Consultation, Geneva, Switzerland, 25 & 26 November 1996 (WHO/PBL/97.60). Geneva: World Health Organization; 1997.
  • World Health Assembly. Global Elimination of Blinding Trachoma. 51st World Health Assembly, Geneva, 16 May 1998, Resolution WHA51.11. Geneva: World Health Organization; 1998.
  • Solomon AW, Zondervan M, Kuper H, Buchan JC, Mabey DCW, Foster A. Trachoma Control: A Guide for Programme Managers. Geneva: World Health Organization; 2006.
  • World Health Organization. Validation of Elimination of Trachoma as a Public Health Problem (WHO/HTM/NTD/2016.8). Geneva: World Health Organization; 2016.
  • Solomon AW, Kurylo E. The global trachoma mapping project. Community Eye Health. 2014;27(85):18.
  • Smith JL, Haddad D, Polack S, et al. Mapping the global distribution of trachoma: why an updated atlas is needed. PLoS Negl Trop Dis. 2011;5(6):e973. doi:10.1371/journal.pntd.0000973.
  • King JD, Jip N, Jugu YS, et al. Mapping trachoma in Nasarawa and Plateau States, central Nigeria. Br J Ophthalmol. 2010;94(1):14–19. doi:10.1136/bjo.2009.165282.
  • Muhammad N, Mohammed A, Isiyaku S, Adamu MD, Gwom A, Rabiu MM. Mapping trachoma in 25 local government areas of Sokoto and Kebbi states, northwestern Nigeria. Br J Ophthalmol. 2014;98(4):432–437. doi:10.1136/bjophthalmol-2013-303703.
  • Adamu MD, Mpyet C, Muhammad N, et al. Prevalence of Trachoma in Niger State, North Central Nigeria: results of 25 population-based prevalence surveys carried out with the global trachoma mapping project. Ophthalmic Epidemiol. 2016;23(Sup 1):63–69. doi:10.1080/09286586.2016.1242757.
  • Alada JJ, Mpyet C, Florea VV, et al. Prevalence of Trachoma in Kogi State, Nigeria: results of four local government area-level surveys from the global trachoma mapping project. Ophthalmic Epidemiol. 2018;25(Sup 1):33–40. doi.org/10.1080/09286586.2017.1409359.
  • Jip NF, King JD, Diallo MO, et al. Blinding trachoma in Katsina state, Nigeria: population-based prevalence survey in ten local government areas. Ophthalmic Epidemiol. 2008;15(5):294–302. doi:10.1080/09286580802256542.
  • Mpyet C, Muhammad N, Mohammed AD, et al. Prevalence of trachoma in Kano State, Nigeria: results of 44 Local Government Area-level surveys. Ophthalmic Epidemiol. 2017;24(3):195–203. doi:10.1080/09286586.2016.1265657.
  • Mpyet C, Muhammad N, Adamu MD, et al. Prevalence of trachoma in Katsina State, Nigeria: results of 34 district-level surveys. Ophthalmic Epidemiol. 2016;23(Sup 1):55–62. doi:10.1080/09286586.2016.1236975.
  • Mpyet C, Muhammad N, Adamu MD, et al. Prevalence of trachoma in Bauchi State, Nigeria: results of 20 local government area-level surveys. Ophthalmic Epidemiol. 2016;23(Sup 1):39–45. doi:10.1080/09286586.2016.1238945.
  • Mpyet C, Muhammad N, Adamu MD, et al. Trachoma mapping in Gombe State, Nigeria: results of 11 local government area surveys. Ophthalmic Epidemiol. 2016;23(6):406–411. doi:10.1080/09286586.2016.1230633.
  • Mpyet C, Ogoshi C, Goyol M. Prevalence of trachoma in Yobe State, north-eastern Nigeria. Ophthalmic Epidemiol. 2008;15(5):303–307. doi:10.1080/09286580802237633.
  • Muhammad N, Mpyet C, Adamu MD, et al. Mapping Trachoma in Kaduna State, Nigeria: results of 23 local government area-level, population-based prevalence surveys. Ophthalmic Epidemiol. 2016;23(Sup 1):46–54. doi:10.1080/09286586.2016.1250918.
  • Ramyil A, Wade P, Ogoshi C, et al. Prevalence of trachoma in Jigawa State, north-western Nigeria. Ophthalmic Epidemiol. 2015;22(3):184–189. doi:10.3109/09286586.2015.1037399.
  • Mpyet C, Lass BD, Yahaya HB, Solomon AW. Prevalence of and risk factors for trachoma in Kano state, Nigeria. PLoS One. 2012;7(7):e40421. doi:10.1371/journal.pone.0040421.
  • Solomon AW, Pavluck A, Courtright P, et al. The Global Trachoma Mapping Project: methodology of a 34-country population-based study. Ophthalmic Epidemiol. 2015;22(3):214–225. doi:10.3109/09286586.2015.1037401.
  • National Population Commission. 2006 Population and Housing Census of the Federal Republic of Nigeria: National and State Population and Housing Tables, Priority Tables (Volume 1). Abuja: National Population Commission; 2009.
  • Courtright P, Gass K, Lewallen S, et al. Global Trachoma Mapping Project: Training for Mapping of Trachoma (Version 2) [Available At: Http://Www.Trachomacoalition.Org/Node/357]. London: International Coalition for Trachoma Control; 2013.
  • Grais RF, Rose AM, Guthmann J-P. Don’t spin the pen: two alternative methods for second-stage sampling in urban cluster surveys. Emerg Themes Epidemiol. 2007;4:8. doi:10.1186/1742-7622-4-8.
  • Turner AG, Magnani RJ, Shuaib M. A not quite as quick but much cleaner alternative to the Expanded Programme on Immunization (EPI) Cluster Survey design. Int J Epidemiol. 1996;25(1):198–203. doi:10.1093/ije/25.1.198.
  • Milligan P, Njie A, Bennett S. Comparison of two cluster sampling methods for health surveys in developing countries. Int J Epidemiol. 2004;33(3):469–476. doi:10.1093/ije/dyh096.
  • World Health Organization, UNICEF. Progress on Sanitation and Drinking Water: 2015 Update and MDG Assessment. Geneva: UNICEF and World Health Organization; 2015.
  • World Health Organization and UNICEF. Core Questions on Drinking-Water and Sanitation for Household Surveys. [Available At: Http://www.wssinfo.org/fileadmin/user_upload/resources/1268174016-JMP_Core_Questions.pdf, Accessed 1 September 2013]. Geneva: World Health Organization/UNICEF; 2006.
  • Thylefors B, Dawson CR, Jones BR, West SK, Taylor HR. A simple system for the assessment of trachoma and its complications. Bull World Health Organ. 1987;65(4):477–483.
  • World Medical Association. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. Jama. 2013;310(20):2191–2194. doi:10.1001/jama.2013.281053.
  • Pavluck A, Chu B, Mann Flueckiger R, Ottesen E. Electronic data capture tools for global health programs: evolution of LINKS, an Android-, web-based system. PLoS Negl Trop Dis. 2014;8(4):e2654. doi:10.1371/journal.pntd.0002654.
  • Evans JR, Solomon AW. Antibiotics for trachoma. Cochrane Database Syst Rev. 2011;3:CD001860.
  • Burton M, Habtamu E, Ho D, Gower EW. Interventions for trachoma trichiasis. Cochrane Database Syst Rev. 2015;11:CD004008.
  • Rabiu MM, Abiose A. Magnitude of trachoma and barriers to uptake of lid surgery in a rural community of northern Nigeria. Ophthalmic Epidemiol. 2001;8(2–3):181–190. doi:10.1076/opep.8.2.181.4167.
  • Mpyet C, Solomon AW. Prevalence and causes of blindness and low vision in leprosy villages of north eastern Nigeria. Br J Ophthalmol. 2005;89(4):417–419. doi:10.1136/bjo.2004.048777.
  • Kalua K, Chisambi A, Chinyanya D, et al. Completion of Baseline Trachoma mapping in Malawi: results of eight population-based prevalence surveys conducted with the global trachoma mapping project. Ophthalmic Epidemiol. 2016;23(Sup 1):32–8. doi:10.1080/09286586.2016.1230224.
  • Bero B, Macleod C, Alemayehu W, et al. Prevalence of and risk factors for trachoma in Oromia regional state of Ethiopia: results of 79 population-based prevalence surveys conducted with the global trachoma mapping project. Ophthalmic Epidemiol. 2016;23(6):392–405. doi:10.1080/09286586.2016.1243717.
  • Elshafie BE, Osman KH, Macleod C, et al. The epidemiology of Trachoma in Darfur States and Khartoum State, Sudan: results of 32 population-based prevalence surveys. Ophthalmic Epidemiol. 2016;23(6):381–391. doi:10.1080/09286586.2016.1243718.
  • Sherief ST, Macleod C, Gigar G, et al. The prevalence of trachoma in Tigray region, Northern Ethiopia: results of 11 population-based prevalence surveys completed as part of the Global Trachoma Mapping Project. Ophthalmic Epidemiol. 2016;23(Sup 1):94–99. doi:10.1080/09286586.2016.1250917.
  • Adera TH, Macleod C, Endriyas M, et al. Prevalence of and risk factors for trachoma in Southern Nations, Nationalities, and Peoples’ Region, Ethiopia: results of 40 population-based prevalence surveys carried out with the Global Trachoma Mapping Project. Ophthalmic Epidemiol. 2016;23(Sup 1):84–93. doi:10.1080/09286586.2016.1247876.
  • Desmond N, Solomon AW, Massae PA, et al. Acceptability of azithromycin for the control of trachoma in Northern Tanzania. Trans R Soc Trop Med Hyg. 2005;99(9):656–663. doi:10.1016/j.trstmh.2005.03.006.
  • Fitzpatrick C, Bangert M, Engels D. Sustainable development goals: diseases that neglect no goals. Nature. 2016;535(7613):493. doi:10.1038/535493c.
  • Bangert M, Molyneux DH, Lindsay SW, Fitzpatrick C, Engels D. The cross-cutting contribution of the end of neglected tropical diseases to the sustainable development goals. Infectious Diseases Poverty. 2017;6(1):73. doi:10.1186/s40249-017-0288-0.
  • Porco TC, Gebre T, Ayele B, et al. Effect of mass distribution of azithromycin for trachoma control on overall mortality in Ethiopian children: A randomized trial. Jama. 2009;302(9):962–968. doi:10.1001/jama.2009.1266.
  • Keenan JD, Ayele B, Gebre T, et al. Childhood mortality in a cohort treated with mass azithromycin for trachoma. Clin Infect Dis. 2011;52(7):883–888. doi:10.1093/cid/cir069.
  • Coles CL, Levens J, Seidman JC, Mkocha H, Munoz B, West S. Mass distribution of azithromycin for trachoma control is associated with short-term reduction in risk of acute lower respiratory infection in young children. Pediatr Infect Dis J. 2012;31(4):341–346. doi:10.1097/INF.0b013e31824155c9.
  • Marks M, Bottomley C, Tome H, et al. Mass drug administration of azithromycin for trachoma reduces the prevalence of genital chlamydia trachomatis infection in the Solomon Islands. Sex Transm Infect. 2016;92:261–265. doi:10.1136/sextrans-2015-052439.
  • Oswald WE, Stewart AE, Kramer MR, et al. Active trachoma and community use of sanitation, Ethiopia. Bull World Health Organ. 2017;95(4):250–260. doi:10.2471/BLT.16.177758.
  • Garn JV, Boisson S, Willis R, et al. Sanitation and water supply coverage thresholds associated with active trachoma: modeling cross-sectional data from 13 countries. PLoS Negl Trop Dis. 2018;12(1):e0006110. doi:10.1371/journal.pntd.0006110.

Appendix

The Global Trachoma Mapping Project Investigators are: Agatha Aboe (1,11), Liknaw Adamu (4), Wondu Alemayehu (4,5), Menbere Alemu (4), Neal D. E. Alexander (9), Ana Bakhtiari (2,9), Berhanu Bero (4), Sarah Bovill (8), Simon J. Brooker (1,6), Simon Bush (7,8), Brian K. Chu (2,9), Paul Courtright (1,3,4,7,11), Michael Dejene (3), Paul M. Emerson (1,6,7), Rebecca M. Flueckiger (2), Allen Foster (1,7), Solomon Gadisa (4), Katherine Gass (6,9), Teshome Gebre (4), Zelalem Habtamu (4), Danny Haddad (1,6,7,8), Erik Harvey (1,6,10), Dominic Haslam (8), Khumbo Kalua (5), Amir B. Kello (4,5), Jonathan D. King (6,10,11), Richard Le Mesurier (4,7), Susan Lewallen (4,11), Thomas M. Lietman (10), Chad MacArthur (6,11), Colin Macleod (3,9), Silvio P. Mariotti (7,11), Anna Massey (8), Els Mathieu (6,11), Siobhain McCullagh (8), Addis Mekasha (4), Tom Millar (4,8), Caleb Mpyet (3,5), Beatriz Muñoz (6,9), Jeremiah Ngondi (1,3,6,11), Stephanie Ogden (6), Alex Pavluck (2,4,10), Joseph Pearce (10), Serge Resnikoff (1), Virginia Sarah (4), Boubacar Sarr (5), Alemayehu Sisay (4), Jennifer L. Smith (11), Anthony W. Solomon (1,2,3,4,5,6,7,8,9,10,11), Jo Thomson (4); Sheila K. West (1,10,11), and Rebecca Willis (2,9). Key: (1) Advisory Committee, (2) Information Technology, Geographical Information Systems, and Data Processing, (3) Epidemiological Support, (4) Ethiopia Pilot Team, (5) Master Grader Trainers, (6) Methodologies Working Group, (7) Prioritisation Working Group (8) Proposal Development, Finances and Logistics, (9) Statistics and Data Analysis, (10) Tools Working Group, (11) Training Working Group